US Patent Issued to Dewpoint Therapeutics on Sept. 23 for "Methods of screening for condensate-associated specificity and uses thereof" (American, German Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,422,437, issued on Sept. 23, was assigned to Dewpoint Therapeutics Inc. (Boston).

"Methods of screening for condensate-associated specificity and uses thereof" was invented by Alexander Szewczak (Needham, Mass.), Ina Poser (Dresden, Germany), Mark Andrew Murcko (Holliston, Mass.), Stephen Paul Hale (Belmont, Mass.) and Bruce Aaron Beutel (Needham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of identifying a compound, such as a test compound, and applications thereof are provided. For example, methods of identifying a compound that preferentially affects, increases, or decreases a level of association of a macromolecule with one or more...